HOME >> MEDICINE >> NEWS
NIAID releases MDR/XDR Tuberculosis research agenda

WHAT: The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), today released its NIAID Research Agenda for Multidrug-Resistant (MDR) and Extensively Drug-Resistant (XDR) Tuberculosis (TB). While focusing on MDR/XDR TB, many of the research priorities identified in this document also relate to drug-sensitive tuberculosis. The research priorities identified in the agenda build on a foundation of ongoing NIAID-supported TB research, which currently comprises more than 300 research projects worldwide.

Diagnosing, treating and controlling the spread of TB has become increasingly complicated because of the HIV/AIDS co-epidemic and the emergence of MDR and XDR TB, which threatens to set TB control efforts back to the pre-antibiotic era. According to NIAID Director Anthony S. Fauci, M.D., NIAID developed this TB research agenda to address MDR/XDR TB with appropriate urgency, while reaffirming the Institutes commitment to a robust program of research focused on all aspects of TB. NIAID is well prepared to foster the development of new TB diagnostics, drugs and vaccines, but given the realities of MDR/XDR TB, the research agenda outlines those areas that need additional attention to enable public health officials to more effectively combat all forms of tuberculosis, he says. He notes that the agenda is a Web-based living document that can be updated as scientific and public health needs and opportunities evolve.

NIAID collaborated with other government and non-government experts to prepare the MDR/XDR TB research agenda. In addition to its review by TB specialists in academia, advocacy groups, international organizations and other government agencies, the draft agenda was presented to the National Advisory Allergy and Infectious Diseases Council, NIAIDs main scientific advisory body.

The research agenda specifically describes six critical areas where additional investiga
'"/>

Contact: Jason Bardi
jbardi@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
6-Jun-2007


Page: 1 2

Related medicine news :

1. NIAID DNA vaccine for H5N1 avian influenza enters human trial
2. NIAID media availability: Examining genetic variability of malaria parasite offers insight
3. NIAID awards $4 million to develop anti-radiation treatments
4. Partnership between NIAID and Sequella yields promising new TB drug for clinical testing
5. NIAID announces leadership for newly restructured HIV/AIDS clinical trials networks
6. NIAID study finds higher dose of flu vaccine improves immune response in the elderly
7. NIAID media availability: New study describes key protein from highly pathogenic H5N1 avian flu virus and how it might mutate
8. NIAID media availability: Understanding influenza infection
9. NIAID researchers show how promising TB drug works
10. NIAID awards $47 million to develop medical countermeasures against radiological, nuclear threats
11. NIAID launches first Phase II trial of a global HIV/AIDS vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/13/2018)... ... November 13, 2018 , ... Nearly 8 in 10 (78%) adults ... basic part of women’s health care, according to a new telephone survey of more ... also showed that more open discussion regarding the full range of methods and health ...
(Date:11/13/2018)... , ... November 13, 2018 , ... ... the upcoming global launch of PreVantage, an all-encompassing family of solutions and partnerships ... outcomes. , The PreVantage brand was developed to address the complex needs ...
(Date:11/13/2018)... , ... November 13, 2018 , ... Any new patient ... now welcome to receive skilled crown lengthening treatments from Drs. Jonathan and Kenneth Nash, ... fortunately, the problem can be easily corrected. Laser gum recontouring is a gentle procedure ...
(Date:11/13/2018)... ... November 13, 2018 , ... One of the only ... Shady Grove Fertility (SGF) presented an unprecedented eleven studies including eight oral ... American Society for Reproductive Medicine’s 2018 Scientific Congress and Expo. , Among ...
(Date:11/11/2018)... Ark. (PRWEB) , ... November 09, 2018 , ... ... announce that it has joined the #GivingTuesday movement. Kicking off the giving season, ... the U.S.) and the widely recognized shopping events Black Friday and Cyber Monday. ...
Breaking Medicine News(10 mins):
(Date:11/13/2018)... Calif. (PRWEB) , ... November 13, 2018 , ... ... a "Happy Gut" this Holiday Season , Who can resist the temptations of ... homemade whipped cream during the holidays? Almost no one! Unfortunately, these continuous yummy ...
(Date:11/13/2018)... ... 13, 2018 , ... Intrepy Healthcare Marketing is a leading ... advertising and physician liaison services is announcing the launch of a new, fully ... their practice can visit the new Intrepy Healthcare Marketing site to ...
(Date:11/13/2018)... ... November 13, 2018 , ... Friends of ... between Israel’s Sheba Medical Center, the largest and most comprehensive hospital in the ... are partnering to better understand pancreatic cancer biology with the goal of improving ...
Breaking Medicine Technology:
Cached News: